Upstream / Downstream

Explore pathways related to this product.

Important Ordering Details

Custom Ordering Details: Product is assembled upon order. Please allow up to three business days for your product to be processed.

Our U.S. Offices Are Closed

Our U.S. offices are closed in observance of Labor Day. We will reopen on Tuesday, September 2nd.

Thank you for your patience.

To Purchase # 6610S

6610S 300 µl (3 nmol) $249.00
$ 0. 00

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

REACTIVITY
H

Western blot analysis of extracts from HeLa cells, transfected with 100 nM SignalSilence® Control siRNA (Unconjugated) #6568 (-) or SignalSilence® IGF-I Receptor siRNA I (+), using IGF-I Receptor β (111A9) Rabbit mAb #3018 (upper) or α-Tubulin (11H10) Rabbit mAb #2125 (lower). The IGF-I Receptor β (111A9) Rabbit mAb confirms silencing of IGF-I Receptor β expression, while the α-Tubulin (11H10) Rabbit mAb is used as a loading control.

Learn more about how we get our images
Image

Product Usage Information

CST recommends transfection with 100 nM IGF-I Receptor siRNA I 48 to 72 hours prior to cell lysis. For transfection procedure, follow protocol provided by the transfection reagent manufacturer. Please feel free to contact CST with any questions on use.

Each vial contains the equivalent of 100 transfections, which corresponds to a final siRNA concentration of 100 nM per transfection in a 24-well plate with a total volume of 300 μl per well.


Storage: SignalSilence® siRNA is supplied in RNAse-free water. Aliquot and store at -20ºC.

Product Description

SignalSilence® IGF-I Receptor siRNA I from Cell Signaling Technology (CST) allows the researcher to specifically inhibit IGF-I Receptor expression using RNA interference, a method whereby gene expression can be selectively silenced through the delivery of double stranded RNA molecules into the cell. IGF-I Receptor siRNA I is 100% homologous with IGF-I Receptor α and β mRNA. All SignalSilence® siRNA products from CST are rigorously tested in-house and have been shown to reduce target protein expression by western analysis.


Quality Control

Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.

Type I insulin-like growth factor receptor (IGF-IR) is a transmembrane receptor tyrosine kinase that is widely expressed in many cell lines and cell types within fetal and postnatal tissues (1-3). Receptor autophosphorylation follows binding of the IGF-I and IGF-II ligands. Three tyrosine residues within the kinase domain (Tyr1131, Tyr1135, and Tyr1136) are the earliest major autophosphorylation sites (4). Phosphorylation of these three tyrosine residues is necessary for kinase activation (5,6). Insulin receptors (IRs) share significant structural and functional similarity with IGF-I receptors, including the presence of an equivalent tyrosine cluster (Tyr1146/1150/1151) within the kinase domain activation loop. Tyrosine autophosphorylation of IRs is one of the earliest cellular responses to insulin stimulation (7). Autophosphorylation begins with phosphorylation at Tyr1146 and either Tyr1150 or Tyr1151, while full kinase activation requires triple tyrosine phosphorylation (8).


1.  Adams, T.E. et al. (2000) Cell. Mol. Life Sci. 57, 1050-1093.

2.  Baserga, R. et al. (2000) Oncogene 19, 5574-5581.

3.  Scheidegger, K.J. et al. (2000) J. Biol. Chem. 275, 38921-38928.

4.  Hernandez-Sanchez, C. et al. (1995) J. Biol. Chem. 270, 29176-29181.

5.  Lopaczynski, W. et al. (2000) Biochem. Biophys. Res. Commun. 279, 955-960.

6.  Baserga, R. et al. (1999) Exp. Cell Res. 253, 1-6.

7.  White, M.F. et al. (1985) J. Biol. Chem. 260, 9470-9478.

8.  White, M.F. et al. (1988) J. Biol. Chem. 263, 2969-2980.


Entrez-Gene Id 3480
Swiss-Prot Acc. P08069


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
SignalSilence® is a trademark of Cell Signaling Technology, Inc.